Patents by Inventor Kavita Vermani

Kavita Vermani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11197835
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Grant
    Filed: December 26, 2019
    Date of Patent: December 14, 2021
    Assignee: Adamas Pharma, LLC
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • Publication number: 20200237686
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: December 26, 2019
    Publication date: July 30, 2020
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • Publication number: 20180263928
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: May 21, 2018
    Publication date: September 20, 2018
    Applicant: Adamas Pharma, LLC
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • Publication number: 20180169082
    Abstract: Oral dosage forms comprising donepezil or a pharmaceutically acceptable salt thereof (e.g., donepezil hydrochloride) alone or in combination with a second active ingredient (e,g,, memantine hydrochloride or a pharmaceutically acceptable salt thereof) for the treatment of Alzheimer's disease are provided. The oral dosage forms comprise donepezil granules that may be sprinkled on food and can significantly improve compliance in patients with swallowing difficulty.
    Type: Application
    Filed: May 15, 2017
    Publication date: June 21, 2018
    Inventors: Mahendra G. Dedhiya, Kavita Vermani, Ashok Katdare
  • Patent number: 9877933
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: January 30, 2018
    Assignee: Adamas Pharma, LLC
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • Patent number: 9867791
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: January 16, 2018
    Assignee: Adamas Pharma, LLC
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • Patent number: 9867792
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: January 16, 2018
    Assignee: Adamas Pharma, LLC
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • Patent number: 9867793
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: January 16, 2018
    Assignee: Adamas Pharma, LLC
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • Publication number: 20170151186
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • Publication number: 20170151184
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • Publication number: 20170151185
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • Publication number: 20170151190
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: February 10, 2017
    Publication date: June 1, 2017
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • Publication number: 20170151183
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • Publication number: 20170151187
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • Publication number: 20160263056
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: September 25, 2015
    Publication date: September 15, 2016
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • Publication number: 20160263055
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: September 23, 2015
    Publication date: September 15, 2016
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • Publication number: 20160263053
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: September 23, 2015
    Publication date: September 15, 2016
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • Publication number: 20160263057
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: September 25, 2015
    Publication date: September 15, 2016
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • Publication number: 20160263054
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: September 23, 2015
    Publication date: September 15, 2016
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • Publication number: 20160256414
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: September 17, 2015
    Publication date: September 8, 2016
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare